乳がんにおけるエストロゲン受容体およびプロゲステロン受容体の免疫組織化学的検査に関する米国臨床腫瘍学会（ASCO）および米国病理医会（CAP）ガイドラインの推奨事項

Hammondら（木曜日）はこの問題を研究しました。

www.synapsesocial.com/papers/6a03324459ea043e4c9e44db — DOI: https://doi.org/10.1200/jop.777003

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer· 2006 · 4,469 citations
2. Protocol for the Examination of Specimens From Patients With Tumors of Bone· 2010 · 40 citations
3. Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.· 2010 · 110 citations
4. Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory· 2008 · 236 citations
5. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer· 2010 · 540 citations